Serum level of under-carboxylated osteocalcin and bone mineral density in early menopausal Norwegian women.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 22127508)

Published in Eur J Nutr on November 30, 2011

Authors

Nina Emaus1, Nguyen D Nguyen, Bjørg Almaas, Gro K Berntsen, Jacqueline R Center, Monika Christensen, Clara G Gjesdal, Anne S Grimsgaard, Tuan V Nguyen, Laila Salomonsen, John A Eisman, Vinjar M Fønnebø

Author Affiliations

1: Department of Health and Care Sciences, Faculty of Health Sciences, University of Tromsø, 9037, Tromsø, Norway. nina.emaus@uit.no

Articles cited by this

Endocrine regulation of energy metabolism by the skeleton. Cell (2007) 10.41

Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA (2005) 5.95

Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54

Assessment of fracture risk. Osteoporos Int (2004) 5.15

Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell (2010) 5.08

Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med (2006) 3.05

A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ (1997) 2.18

Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab (1998) 2.07

Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab (1997) 2.04

Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone (1996) 1.80

Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest (1993) 1.78

Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res (2000) 1.71

Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women. Calcif Tissue Int (2000) 1.66

Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab (2008) 1.65

Dietary and nondietary determinants of vitamin K biochemical measures in men and women. J Nutr (2002) 1.52

Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver. Am J Gastroenterol (2002) 1.42

Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr (1999) 1.41

Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis (2001) 1.34

Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr (2003) 1.30

Associations between vitamin K biochemical measures and bone mineral density in men and women. J Clin Endocrinol Metab (2004) 1.29

Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int (2007) 1.22

Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. Nutrition (2001) 1.13

Determinants of vitamin K status in humans. Vitam Horm (2008) 1.12

Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res (1994) 1.09

Relationships between undercarboxylated osteocalcin and vitamin K intakes, bone turnover, and bone mineral density in healthy women. Clin Nutr (2010) 1.08

Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women. J Bone Miner Res (2009) 1.08

A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy. Maturitas (1999) 1.03

Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial. Osteoporos Int (2009) 0.99

Effect of continuous combined therapy with vitamin K(2) and vitamin D(3) on bone mineral density and coagulofibrinolysis function in postmenopausal women. Maturitas (2002) 0.99

Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study. Am J Med (2004) 0.97

Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials. J Bone Miner Metab (2011) 0.96

Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency. Bone (2002) 0.93

Vitamin K and bone health. Nutrition (2001) 0.92

Determinants and correlates of serum undercarboxylated osteocalcin. Ann Nutr Metab (2008) 0.90

Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Calcif Tissue Int (1998) 0.89

Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease. Bone (2004) 0.87

Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: a comparison with the effect of etidronate. J Orthop Sci (2001) 0.86

Menaquinone-7 regulates the expressions of osteocalcin, OPG, RANKL and RANK in osteoblastic MC3T3E1 cells. Int J Mol Med (2005) 0.85

Effects of vitamin K on calcium and bone metabolism. Curr Opin Clin Nutr Metab Care (2001) 0.85

Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis. Calcif Tissue Int (2000) 0.85

Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis. J Orthop Sci (2000) 0.83

Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia. J Obstet Gynaecol Res (2006) 0.81

Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts. Calcif Tissue Int (1996) 0.81

Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. Bone (1998) 0.81

Role of K vitamins in the regulation of tissue calcification. J Bone Miner Metab (2001) 0.80

Promotion of bone formation by fermented soybean (Natto) intake in premenopausal women. J Nutr Sci Vitaminol (Tokyo) (2004) 0.80

Update on the role of vitamin K in skeletal health. Nutr Rev (2008) 0.79

Vitamin K and bone: past, present, and future. J Bone Miner Res (2009) 0.79

Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women. Gynecol Endocrinol (2006) 0.78

Time-dependent effects of vitamin K2 (menatetrenone) on bone metabolism in postmenopausal women. Endocr J (2002) 0.77

1,25-Dihydroxyvitamin D3 promotes vitamin K2 metabolism in human osteoblasts. Osteoporos Int (2001) 0.76

Menaquinone-7 regulates gene expression in osteoblastic MC3T3E1 cells. Int J Mol Med (2007) 0.76

Association between serum undercarboxylated osteocalcin and bone density and/or quality in early postmenopausal women. Nutrition (2003) 0.75

Protective effect of vitamins K2 and D3 on prednisolone-induced loss of bone mineral density in the lumbar spine. Am J Kidney Dis (2004) 0.75

Articles by these authors

Predictive value of BMD for hip and other fractures. J Bone Miner Res (2005) 6.46

Multiple genetic loci for bone mineral density and fractures. N Engl J Med (2008) 6.35

Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA (2009) 5.60

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48

Effects of a medical emergency team on reduction of incidence of and mortality from unexpected cardiac arrests in hospital: preliminary study. BMJ (2002) 5.15

Risk of subsequent fracture after low-trauma fracture in men and women. JAMA (2007) 4.19

New sequence variants associated with bone mineral density. Nat Genet (2008) 3.43

A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res (2004) 2.92

Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits. Nature (2013) 2.55

Alcohol intake as a risk factor for fracture. Osteoporos Int (2004) 2.34

Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet (2011) 2.34

The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr (2006) 2.15

Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density. J Bone Miner Res (2010) 1.95

Association between Agent Orange and birth defects: systematic review and meta-analysis. Int J Epidemiol (2006) 1.82

Residual lifetime risk of fractures in women and men. J Bone Miner Res (2007) 1.82

Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res (2004) 1.79

Vitamin D deficiency in critically ill patients. N Engl J Med (2009) 1.73

Investigation of incidental hypercalcaemia. BMJ (2009) 1.70

Association between clinically abnormal observations and subsequent in-hospital mortality: a prospective study. Resuscitation (2004) 1.64

7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture. Med J Aust (2004) 1.63

A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res (2014) 1.56

WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk. PLoS Genet (2012) 1.55

Identification of high-risk individuals for hip fracture: a 14-year prospective study. J Bone Miner Res (2005) 1.54

Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study. J Bone Miner Res (2005) 1.51

Effect of vegetarian diets on bone mineral density: a Bayesian meta-analysis. Am J Clin Nutr (2009) 1.49

Relationship between body mass index and fracture risk is mediated by bone mineral density. J Bone Miner Res (2014) 1.48

Genetic profiling and individualized assessment of fracture risk. Nat Rev Endocrinol (2013) 1.47

A meta-analysis of milk intake and fracture risk: low utility for case finding. Osteoporos Int (2004) 1.39

The prevalence and correlates of physical inactivity among adults in Ho Chi Minh City. BMC Public Health (2008) 1.36

Laparoscopic entry: a literature review and analysis of techniques and complications of primary port entry. Aust N Z J Obstet Gynaecol (2002) 1.31

Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. Arch Intern Med (2008) 1.29

Vitamin D deficiency in the intensive care unit: an invisible accomplice to morbidity and mortality? Intensive Care Med (2009) 1.29

Association between lean mass, fat mass, and bone mineral density: a meta-analysis. J Clin Endocrinol Metab (2013) 1.27

Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer. Gastroenterology (2009) 1.27

Osteoporosis: underrated, underdiagnosed and undertreated. Med J Aust (2004) 1.24

Femoral neck bone loss predicts fracture risk independent of baseline BMD. J Bone Miner Res (2005) 1.24

Association between vitamin D insufficiency and tuberculosis in a Vietnamese population. BMC Infect Dis (2010) 1.23

Diabetes mellitus and the risk of non-vertebral fractures: the Tromsø study. Osteoporos Int (2005) 1.22

Predicting fractures in an international cohort using risk factor algorithms without BMD. J Bone Miner Res (2011) 1.22

Timing of repeat BMD measurements: development of an absolute risk-based prognostic model. J Bone Miner Res (2009) 1.20

Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. Eur J Endocrinol (2009) 1.19

Compound risk of high mortality following osteoporotic fracture and refracture in elderly women and men. J Bone Miner Res (2013) 1.19

Osteoporosis medication and reduced mortality risk in elderly women and men. J Clin Endocrinol Metab (2011) 1.18

Multistage genome-wide association meta-analyses identified two new loci for bone mineral density. Hum Mol Genet (2013) 1.17

Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index. Am J Med (2009) 1.17

Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer. Gynecol Oncol (2011) 1.17

Risk factors for in-hospital post-hip fracture mortality. Bone (2011) 1.17

Bone resorption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology study. J Bone Miner Res (2004) 1.16

Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed. Eur J Endocrinol (2010) 1.16

Risk factors for fracture in nonosteoporotic men and women. J Clin Endocrinol Metab (2006) 1.14

Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression. J Biol Chem (2007) 1.14